- Home
- APTO
as 07-01-2024 4:00pm EST
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
| Founded: | 1986 | Country: | Canada |
| Employees: | N/A | City: | TORONTO |
| Market Cap: | 16.8M | IPO Year: | N/A |
| Target Price: | $14.83 | AVG Volume (30 days): | 66.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.71 - $5.10 | Next Earning Date: | 08-08-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Aptose Biosciences Inc. News
APTO Breaking Stock News: Dive into APTO Ticker-Specific Updates for Smart Investing
GlobeNewswire
14 days ago
Aptose Announces Results from Annual and Special Meeting of Shareholders
GlobeNewswire
18 days ago
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress
Zacks
19 days ago
Aptose Biosciences (APTO) Upgraded to Buy: What Does It Mean for the Stock?
Yahoo Finance Video
22 days ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
22 days ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Reuters
22 days ago
California seeks company profits in Big Oil climate lawsuit
USA TODAY
22 days ago
S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead
GlobeNewswire
22 days ago
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
Share on Social Networks:
Disclaimer
The information presented on this page, "APTO Aptose Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.